Zobrazeno 1 - 10
of 15
pro vyhledávání: ''
Autor:
Oussama Ouadfel, Z. Raissuni, Mehdi Benali, Adil Najdi, D. Alkattan, A. Aajal, N. Zergoune, O. Boukouk, B. El Boussaadani, Chakib Benajiba, H. Bendoudouch, Zaynab Mahdi, L. Hara
Publikováno v:
Annales De Cardiologie et D'Angeiologie
Introduction L’infection à Sars COV-2 causant la maladie du covid-19 a pris naissance en décembre 2019 à Wuhan en Chine. Puis, elle s’est propagée rapidement à plus de 100 pays en moins de trois mois. Le 11 mars 2020, l’OMS déclarait offi
Autor:
Olivier Dubourg, Kevin Zarca, Nicolas Danchin, Thibaut Caruba, Brigitte Sabatier, Karine Chevreul, Benjamin Cadier, Yves Juillière
Publikováno v:
Archives of Cardiovascular Diseases. (11):576-588
Background Few studies have analyzed the cost of treatment of chronic angina pectoris, especially in European countries. Aim To determine, using a modeling approach, the cost of care in 2012 for 1 year of treatment of patients with stable angina, acc
Autor:
Ariel Cohen, Emanuele Di Angelantonio
Publikováno v:
Archives of Cardiovascular Diseases. (3):139-141
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):77-78
BackgroundIn the EUROPA study, perindopril 8 mg/day significantly reduced the combined primary end point (PEP) of cardiovascular death, nonfatal myocardial infarction (MI), and/or resuscitated cardiac arrest by 20%, compared with placebo, after 4.2 y
Autor:
Laurent J. Feldman, Gabriel Steg, Mathilde Labalette-Bart, Marianne Zeller, Yves Cottin, Jean-Michel Julliard, Ronan Roussel
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):2-3
BackgroundContrast-induced nephropathy (CIN) is a frequent complication in patients undergoing percutaneous coronary intervention (PCI), associated with increased mortality. The impact of metformin, which has potential interactions with renal functio
Autor:
Matteo E. Mangoni, Stéphanie Barrère-Lemaire, Viviana Delgado Betancourt, Pietro Mesirca, Isabelle Bidaud, Aurélie Covinhes, Jörg Striessnig, Joël Nargeot, Christophe Piot
Publikováno v:
Archives of Cardiovascular Diseases Supplements. :30-31
Myocardial infarction (MI) is the major cause of cardiovascular mortality in western countries. Early reperfusion is the only treatment recommended to reduce infarct size (IS), a crucial prognostic factor of morbidity and mortality. However, reperfus
Autor:
Sanae Boulaamayl El Fatemi
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (2):195
The purpose of this study is to evaluate predictive factor and the impact of myocardial viability assessment by cardiac magnetic resonance imaging (CMRI) and of revascularization therapy in 121 patients with coronary artery disease (CAD). Between Sep
Autor:
Zohra Dridi, Habib Gamra, Fethi Betbout, Marouen Mahjoub, Dorsafm Layah, Ghassen Chniti, Mejdi Ben Massoud, Majed Hassine
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):14
IntroductionRight ventricular (RV) infarction is a serious and life threatening condition which mainly complicates an inferior wall myocardial infarction (MI). In the literature, data for predictive factors of mortality in this setting remains scarce
Autor:
Emmanuel Valentin, Monique Dehoux, Joelle Benessiano, Gabriel Steg, Pascale Bonnet, Armelle Desplanques
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):3
sPLA2 and Lp-PLA2 are currently being evaluated as potential markers and therapeutic targets in coronary artery disease. We hypothesized that their measurement, in parallel with CRP, could correlate to the risk of death or myocardial infarction (MI)
Autor:
Sameh Haj Taieb, Haifa Sanhaji, Naziha Kaabachi, Moncef Feki, Rachid Mechmeche, Amani Kallel, Souheil Omar, Monia Elasmi, Samir Ben Ali, Riadh Jemaa, Yousra Sediri, Sami Mourali
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):86
BackgroundPathophysiological role of arginase I (ARG I) on vascular disease have been extensively documented, and some recent studies support a role for ARG I in the initiation, development and complications of coronary artery disease (CAD). The aim